
We employ both established and customised GMP methods to evaluate the identity, purity, potency, and quality of a diverse range of materials used in a wide array of bioprocesses.
Timing is everything in new medicine development. The speed at which you can pass milestones, and ultimately how quickly you can get your treatment to market, will come down to how fast you can navigate clinical trials and regulatory compliance.
The Eurofins BioPharma Product Testing network of laboratories has become the biosafety testing partner of choice for those who urgently need support with drug development solutions at any stage from pre-clinical through to commercialisation.
Our expertly staffed facilities are strategically located to offer you cost-efficiency and speed, while our network of laboratories provides biosafety testing services to a level of precision and compliance that will empower your biologics development and manufacturing with the highest confidence.
We employ both established and customised GMP methods to evaluate the identity, purity, potency, and quality of a diverse range of materials used in a wide array of bioprocesses.
Faster cell banking scheduling. Extensive cell bank characterisation. Expansive LN2 capacity for cell bank storage. Eurofins BPT can be your single-source solution for all your cell line requirements.
Our quality programme has been engineered to meet the highest quality expectations and global regulatory compliance requirements.
Streamlined sample delivery and receipt processes enable seamless communication between our network of laboratories and your own, providing you with the options of 21 or 35-day standard turnaround times.
More than 80 years of combined experience in viral clearance and viral safety has enabled Eurofins BPT to develop suite of comprehensive, fully cGMP-compliant viral safety solutions to suit every stage of biological product development, manufacturing, and release.